04-1648 Sigma-AldrichGoat Anti-Rabbit IgG Fab Antibody, clone RMG01
Goat Anti-Rabbit IgG Fab, clone RMG01, Cat. No. 04-1648, is a highly specific goat monoclonal antibody, that targets Rabbit IgG Fab and has been tested in Western Blotting and ELISA.
More>> Goat Anti-Rabbit IgG Fab, clone RMG01, Cat. No. 04-1648, is a highly specific goat monoclonal antibody, that targets Rabbit IgG Fab and has been tested in Western Blotting and ELISA. Less<<Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| Species Reactivity | Key Applications | Host | Format | Antibody Type |
|---|---|---|---|---|
| Rb | ELISA, WB | Gt | Purified | Monoclonal Antibody |
| Description | |
|---|---|
| Catalogue Number | 04-1648 |
| Description | Goat Anti-Rabbit IgG Fab Antibody, clone RMG01 |
| References |
|---|
| Product Information | |
|---|---|
| Format | Purified |
| Presentation | Goat monoclonal in PBS with 1% BSA and 0.09% sodium azide. |
| Quality Level | MQ100 |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Packaging Information | |
|---|---|
| Material Size | 100 μg |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 04-1648 | 04055977181906 |
Documentation
Goat Anti-Rabbit IgG Fab Antibody, clone RMG01 Certificates of Analysis
| Title | Lot Number |
|---|---|
| Goat Anti-Rabbit IgG Fab, -QVP1504137 | QVP1504137 |
| Goat Anti-Rabbit IgG Fab, clone RMG01 - VP2109021 | VP2109021 |
| Goat Anti-Rabbit IgG Fab, clone RMG01 - VP2304041 | VP2304041 |
| Goat Anti-Rabbit IgG Fab, clone RMG01 - VP2508220 | VP2508220 |
| Goat Anti-Rabbit IgG Fab, clone RMG01 -VP1611241 | VP1611241 |
Technical Info
| Title |
|---|
| Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
| White Paper: Further considerations of antibody validation and usage. |



